Upgrade to SI Premium - Free Trial

DaVita (DVA) PT Raised to $235 at UBS

May 7, 2026 9:39 AM
UBS analyst AJ Rice raised the price target on DaVita (NYSE: DVA) to $235.00 (from $190.00) while maintaining a Buy rating.

Categories

Analyst PT Change